Quality in Laboratory Hemostasis and Thrombosis 2008
DOI: 10.1002/9781444303575.ch18
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring Oral Anticoagulant Therapy

Abstract: Since 1984, when I was matriculated as a medical student, I have taken an interest in all the three major areas, but my main occupation in the past 12 years has been with the quantitative epistemological discipline of statistics, which deals with the collection, analysis, interpretation, and presentation of numerical data. The formal foundation for theoretical statistics is mathematical statistics, in which I took a master's degree (MSc) in 1995.Concurrently, in the past nine years, and especially since 1995, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 79 publications
(139 reference statements)
0
5
0
Order By: Relevance
“…Furthermore, some protocols that use a first fixed loading dose of 10 mg are unsuitable for elderly patients in whom they carry a risk of severe overanticoagulation. Moreover, in the high-range INR values obtained with these protocols (> 4.5), INR measurement lacks accuracy, which hampers dosage prediction [27]. One limitation of our study is the lack of patient follow-up beyond the achievement of the maintenance dose.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Furthermore, some protocols that use a first fixed loading dose of 10 mg are unsuitable for elderly patients in whom they carry a risk of severe overanticoagulation. Moreover, in the high-range INR values obtained with these protocols (> 4.5), INR measurement lacks accuracy, which hampers dosage prediction [27]. One limitation of our study is the lack of patient follow-up beyond the achievement of the maintenance dose.…”
Section: Discussionmentioning
confidence: 93%
“…A fixed 4-mg dose used for 3 days has been shown to be safe, avoiding marked over-or under-anticoagulation [19,20], and to produce INR 3 values in the 1.5-4.5 range in most patients. In this range, INR measurement accuracy and precision are optimal, which facilitates dose prediction [27]. In very different settings, clinical warfarin dosing algorithms incorporating INR values obtained in the first week successfully predicted the warfarin maintenance dose, and some of them demonstrated a good safety profile [8,[13][14][15][28][29][30].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, they do not require regular laboratory monitoring to adjust the dosage, whereas vitamin K antagonists require monitoring with the use of the INR, the validity of which has been questioned in patients with chronic liver disease. 57 Other potential advantages of these new drugs over low-molecularweight heparin are their oral route of administration and their mechanism of action, which is independent of antithrombin (low in these patients). However, specially designed clinical trials are needed because patients with chronic liver disease are usually excluded from the randomized clinical trials of these drugs.…”
Section: Portal-vein Thrombosismentioning
confidence: 99%
“…Monitoring anticoagulation in cirrhosis Conventional INR is unreliable in cirrhosis [112] and the anti‐FXa activity measured in non‐anticoagulated patients is negatively correlated with the severity of liver disease and positively with antithrombin levels [111]. Therefore, monitoring VKA and LMWH in patients with cirrhosis remains a challenge.…”
mentioning
confidence: 99%